Year |
Citation |
Score |
2009 |
Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, Futscher BW. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicology and Applied Pharmacology. 235: 39-46. PMID 19061910 DOI: 10.1016/J.Taap.2008.10.013 |
0.698 |
|
2008 |
Wozniak RJ, Keles S, Lugus JJ, Young KH, Boyer ME, Tran TM, Choi K, Bresnick EH. Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. Molecular and Cellular Biology. 28: 6681-94. PMID 18779319 DOI: 10.1128/Mcb.01061-08 |
0.306 |
|
2008 |
Wozniak RJ, Bresnick EH. Epigenetic control of complex loci during erythropoiesis. Current Topics in Developmental Biology. 82: 55-83. PMID 18282517 DOI: 10.1016/S0070-2153(07)00003-8 |
0.427 |
|
2007 |
Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene. 26: 77-90. PMID 16799634 DOI: 10.1038/Sj.Onc.1209763 |
0.764 |
|
2006 |
Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Research. 66: 10664-70. PMID 17090521 DOI: 10.1158/0008-5472.Can-06-2761 |
0.783 |
|
2005 |
Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress AE. Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia (New York, N.Y.). 7: 799-808. PMID 16229802 DOI: 10.1593/Neo.05274 |
0.796 |
|
2005 |
Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodríguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Research : Bcr. 7: R669-80. PMID 16168112 DOI: 10.1186/Bcr1273 |
0.694 |
|
2004 |
Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia (New York, N.Y.). 6: 187-94. PMID 15153330 DOI: 10.1593/Neo.3292 |
0.684 |
|
2003 |
Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene. 22: 3624-34. PMID 12789271 DOI: 10.1038/Sj.Onc.1206545 |
0.726 |
|
2002 |
Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genetics. 31: 175-9. PMID 12021783 DOI: 10.1038/Ng886 |
0.783 |
|
Show low-probability matches. |